BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32733438)

  • 41. Surfactant protein D induces immune quiescence and apoptosis of mitogen-activated peripheral blood mononuclear cells.
    Pandit H; Thakur G; Koippallil Gopalakrishnan AR; Dodagatta-Marri E; Patil A; Kishore U; Madan T
    Immunobiology; 2016 Feb; 221(2):310-22. PubMed ID: 26563748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profiles.
    Hegde PS; Rusnak D; Bertiaux M; Alligood K; Strum J; Gagnon R; Gilmer TM
    Mol Cancer Ther; 2007 May; 6(5):1629-40. PubMed ID: 17513611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mycophenolic acid potentiates HER2-overexpressing SKBR3 breast cancer cell line to induce apoptosis: involvement of AKT/FOXO1 and JAK2/STAT3 pathways.
    Aghazadeh S; Yazdanparast R
    Apoptosis; 2016 Nov; 21(11):1302-1314. PubMed ID: 27651367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
    Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
    Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation.
    De Iuliis F; Salerno G; Giuffrida A; Milana B; Taglieri L; Rubinacci G; Giantulli S; Terella F; Silvestri I; Scarpa S
    Tumour Biol; 2016 Feb; 37(2):2603-11. PubMed ID: 26392111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors.
    Yamazoe M; Nishitani C; Takahashi M; Katoh T; Ariki S; Shimizu T; Mitsuzawa H; Sawada K; Voelker DR; Takahashi H; Kuroki Y
    J Biol Chem; 2008 Dec; 283(51):35878-88. PubMed ID: 18990700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulating Three-Dimensional Microenvironment with Hyaluronan of Different Molecular Weights Alters Breast Cancer Cell Invasion Behavior.
    Zhao YF; Qiao SP; Shi SL; Yao LF; Hou XL; Li CF; Lin FH; Guo K; Acharya A; Chen XB; Nie Y; Tian WM
    ACS Appl Mater Interfaces; 2017 Mar; 9(11):9327-9338. PubMed ID: 28240531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sensitization of breast cancer cells to radiation by trastuzumab.
    Liang K; Lu Y; Jin W; Ang KK; Milas L; Fan Z
    Mol Cancer Ther; 2003 Nov; 2(11):1113-20. PubMed ID: 14617784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells.
    Yadav B; Taurin S; Larsen L; Rosengren RJ
    Int J Oncol; 2012 Sep; 41(3):1119-27. PubMed ID: 22710975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physiological concentration of calcium inhibits elastase-induced cleavage of a functional recombinant fragment of surfactant protein D.
    Duvoix A; Mackay RM; Henderson N; McGreal E; Postle A; Reid K; Clark H
    Immunobiology; 2011; 216(1-2):72-9. PubMed ID: 20378199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histone deacetylase inhibitors alter the expression of molecular markers in breast cancer cells via microRNAs.
    Shi Y; Jia Y; Zhao W; Zhou L; Xie X; Tong Z
    Int J Mol Med; 2018 Jul; 42(1):435-442. PubMed ID: 29620153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apigenin induces caspase-dependent apoptosis by inhibiting signal transducer and activator of transcription 3 signaling in HER2-overexpressing SKBR3 breast cancer cells.
    Seo HS; Ku JM; Choi HS; Woo JK; Jang BH; Go H; Shin YC; Ko SG
    Mol Med Rep; 2015 Aug; 12(2):2977-84. PubMed ID: 25936427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer.
    Dagher E; Simbault L; Abadie J; Loussouarn D; Campone M; Nguyen F
    Tumour Biol; 2020 Jan; 42(1):1010428319901052. PubMed ID: 31959092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells.
    Golubovskaya V; Beviglia L; Xu LH; Earp HS; Craven R; Cance W
    J Biol Chem; 2002 Oct; 277(41):38978-87. PubMed ID: 12167618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nucleic acid is a novel ligand for innate, immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin.
    Palaniyar N; Nadesalingam J; Clark H; Shih MJ; Dodds AW; Reid KB
    J Biol Chem; 2004 Jul; 279(31):32728-36. PubMed ID: 15145932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Influence of the HLDF differentiation factor on the production of cytokines by bio-tissues of breast tissue in its non-malignant diseases and in invasive carcinoma of a non-specific type].
    Autenshlyus AI; Studenikina AA; Mikhaylova YS; Proskura AV; Varaksin NA; Sidorov SV; Bogachuk AP; Lipkin VM; Lyakhovich VV
    Biomed Khim; 2020 Nov; 66(6):485-493. PubMed ID: 33372907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin.
    Jandial DD; Krill LS; Chen L; Wu C; Ke Y; Xie J; Hoang BH; Zi X
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28335434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
    Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
    J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.